Skip to main content

Please select
your location below

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

By selecting the International view, you verify that you reside outside of the USA and you wish to view Diasorin's International Product Information.
This material is intended for International (non-USA) site visitors only.

Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professional operators.

ご注意

現在、日本語に対応しているのは、Luminex LTGのセクションとLuminex LTGのサービス＆サポートページのみです。

Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese.

Document repository

Dialog

Product list

Catalog

Need more information?

Contact us

Direct links

Select product by product line

TM
Tumor markers

Tumor markers

Support your clinicians in the diagnosis and monitoring of tumors.
Automated CLIA solution to determinate the most relevant tumor markers used in oncology.

Search in our catalog

Let us help you:

Select panel

Select product name

Sort by
LIAISON® XL

LIAISON® AFP

Automated CLIA assay for the quantitative determination of alpha-fetoprotein (AFP) in human serum as well as in EDTA and heparinized human plasma or amniotic fluid. The test can be used as an aid for pregnancy monitoring and as an aid during the follow-up of tumor patients.
Discover more
LIAISON® XL

LIAISON® B2-Microglobulin

Automated CLIA assay for the quantitative determination of β2-microglobulin (B2M) in human serum, plasma and urine. This test can be used as an aid in the diagnosis of active rheumatoid arthritis and kidney disease. The test can be used as an aid in the evaluation of the severity and prognosis of certain cancers including multiple myeloma and some lymphomas.
Discover more
LIAISON® XL

LIAISON® CA 125II TM

Automated CLIA assay for the quantitative determination of CA 125 antigen in human serum as well as in EDTA or heparinized human plasma. The test can be used as an aid during the follow-up of patients with primary invasive ovarian carcinoma.
Discover more
LIAISON® XL

LIAISON® CA 15-3®

Automated CLIA assay for the quantitative determination of the CA 15-3® antigen in human serum as well as EDTA and heparinized plasma. The test can be used as an aid during the follow-up of patients with breast carcinoma.
Discover more
LIAISON® XL

LIAISON® CA 19-9TM

Automated CLIA assay for the quantitative determination of the CA 19-9™ antigen in human serum as well as EDTA or citrated human plasma. The test can be used as an aid during the follow-up of patients with gastrointestinal tumors.
Discover more
LIAISON® XL

LIAISON® Calcitonin II Gen

Automated CLIA assay for the quantitative determination of calcitonin in human serum. The determination of calcitonin is an aid in the diagnosis of calcitonin disorders and in the management of medullary thyroid carcinoma.
Discover more
LIAISON® XL

LIAISON® CEA

Automated CLIA assay for the quantitative determination of carcinoembryonic antigen (CEA) in human serum as well as in EDTA or heparinized human plasma. The test can be used as an aid during the follow-up of cancer patients.
Discover more
LIAISON® XL / LIAISON® XS

LIAISON® fPSA

Automated CLIA assay for the quantitative determination of free human prostate-specific antigen (fPSA) in human serum and plasma (EDTA or heparinized). The combined use of free PSA and total PSA is an aid in the discrimination of benign and malignant disease with increased specificity of early detection of prostate cancer.
Discover more
LIAISON® XL

LIAISON® NSE

Automated CLIA assay for the quantitative determination of neuron-specific enolase (NSE) in human serum and CSF. The test can be used as an aid for the management of patients with suspected or diagnosed neuroblastoma or small cell lung carcinoma.
Discover more
LIAISON® XL

LIAISON® PSA

Automated CLIA assay for the quantitative determination of human prostate-specific antigen (PSA) in human serum and plasma (heparinized, EDTA). The combined use of free PSA and total PSA is an aid in the discrimination of benign and malignant disease with increased specificity of early detection of prostate cancer.
Discover more
LIAISON® XL / LIAISON® XS

LIAISON® PSA II Gen

Automated CLIA immunoassay for the quantitative in vitro detection of total prostate specific antigen (PSA) in human serum, lithium heparin plasma and K2-EDTA plasma. It is intended for use in conjunction with DRE, clinical evaluation and other diagnostic procedures in males aged 50 years or older to aid in the detection of prostate cancer. In addition, it can be used as an aid in the management of patients with prostate cancer (PCa).
Discover more
LIAISON® XL

LIAISON® S100

Automated CLIA assay for the determination of protein S-100B in human serum and CSF (cerebrospinal fluid). The test can be used as an aid in the diagnosis of malignant melanoma and as an aid of diagnosis and prognosis of traumatic brain injury.
Discover more
LIAISON® XL

LIAISON® Thymidine Kinase

Automated CLIA assay for the quantitative determination of Thymidine Kinase (TK) activity in human serum or EDTA plasma. Determination of serum Thymidine Kinase activity is useful for prognosis and monitoring of patients with hematological malignancies. Assay results should be used in conjunction with other clinical and laboratory data to assist in the diagnosis and management of conditions involving hematologic malignancies.
Discover more
LIAISON® XL

LIAISON® TPA® -M

Automated CLIA assay for the quantitative determination of tissue polypeptide antigen, TPA®, in human serum. This test can be used an aid in the diagnosis of patients with carcinomas such as lung cancer, breast cancer, bladder cancer and therapy monitoring after tumor surgery or treatment.
Discover more